GCA
AGN

Gideon Capital Advisors’s Allergan plc AGN Stock Holding History

Gideon Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,820
Closed -$730K – 244
2019
Q4 		$730K Buy
+3,820
New +$689K 0.25% 140
2019
Q2 		– Sell
-1,739
Closed -$255K – 483
2019
Q1 		$255K Buy
+1,739
New +$252K 0.09% 314
2015
Q2 		– Sell
-1,423
Closed -$424K – 335
2015
Q1 		$424K Buy
1,423
+123
+9% +$35.1K 0.17% 167
2014
Q4 		$335K Buy
+1,300
New +$325K 0.16% 156
2014
Q3 		– Sell
-4,115
Closed -$918K – 383
2014
Q2 		$918K Buy
+4,115
New +$852K 0.33% 98

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Gideon Capital Advisors's AGN Position: Q1 2020 in Review

Gideon Capital Advisors sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 3,820 shares — an estimated $730K sold.

Gideon Capital Advisors first reported a position in AGN in Q2 2014 and held it in 5 quarters. The position peaked at $918K in Q2 2014. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Gideon Capital Advisors reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Gideon Capital Advisors sold 3,820 Allergan plc shares in Q1 2020, an estimated $730K.
  • Gideon Capital Advisors first reported a position in Allergan plc in Q2 2014 and held it in 5 quarters.
  • Gideon Capital Advisors's Allergan plc position peaked at $918K in Q2 2014.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Gideon Capital Advisors's 13F filing for Q1 2020.